Thomas F. Ryan, Jr., insider at Repligen

Thomas F. Ryan, Jr. Insider Information

Director of Repligen
Thomas F. Ryan Jr. has served as a director of Repligen since September 2003. Mr. Ryan is currently an investor in various private companies. Mr. Ryan served as the President and Chief Operating Officer of the American Stock Exchange from October 1995 to April 1999. Prior to 1995, he held a variety of positions at the investment banking firm of Kidder, Peabody & Co., Inc., serving as the firm’s Chairman in 1995. He holds a B.A. from Boston College and is a graduate of the Boston Latin School. Mr. Ryan is a director for the New York State Independent System Operator and a director for BNY Mellon Asset Management Mutual Funds Board. Mr. Ryan’s qualifications to sit on the Company’s Board of Directors include his years of experience in the areas of securities trading and investment banking.

What is Thomas F. Ryan, Jr.'s net worth?

The estimated net worth of Thomas F. Ryan, Jr. is at least $621,888.96 as of March 3rd, 2021. Mr. Ryan, Jr. owns 2,464 shares of Repligen stock worth more than $621,889 as of August 17th. This net worth approximation does not reflect any other assets that Mr. Ryan, Jr. may own. Learn More about Thomas F. Ryan, Jr.'s net worth.

How do I contact Thomas F. Ryan, Jr.?

The corporate mailing address for Mr. Ryan, Jr. and other Repligen executives is 41 SEYON STREET BUILDING 1 SUITE 100, WALTHAM MA, 02453. Repligen can also be reached via phone at (781) 250-0111 and via email at [email protected] Learn More on Thomas F. Ryan, Jr.'s contact information.

Has Thomas F. Ryan, Jr. been buying or selling shares of Repligen?

Thomas F. Ryan, Jr. has not been actively trading shares of Repligen during the past quarter. Most recently, Thomas F. Ryan, Jr. sold 2,000 shares of the business's stock in a transaction on Tuesday, March 1st. The shares were sold at an average price of $198.03, for a transaction totalling $396,060.00. Learn More on Thomas F. Ryan, Jr.'s trading history.

Who are Repligen's active insiders?

Repligen's insider roster includes Nicolas Barthelemy (Director), James Bylund (SVP), Karen Dawes (Director), Christine Gebski (Insider), Anthony Hunt (CEO), Ralf Kuriyel (VP), Thomas Ryan, Jr. (Director), and Jon Snodgres (CFO). Learn More on Repligen's active insiders.

Are insiders buying or selling shares of Repligen?

In the last year, insiders at the biotechnology company sold shares 15 times. They sold a total of 122,903 shares worth more than $29,857,691.92. The most recent insider tranaction occured on August, 11th when VP Ralf Kuriyel sold 4,840 shares worth more than $1,230,908.80. Insiders at Repligen own 1.1 % of the company. Learn More about insider trades at Repligen.

Information on this page was last updated on 8/11/2022.

Thomas F. Ryan, Jr. Insider Trading History at Repligen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2022Sell2,000$198.03$396,060.00View SEC Filing Icon  
11/4/2021Sell1,000$288.00$288,000.00View SEC Filing Icon  
8/4/2021Sell780$250.50$195,390.00View SEC Filing Icon  
3/3/2021Sell1,000$205.00$205,000.002,464View SEC Filing Icon  
11/11/2020Sell934$187.73$175,339.822,398View SEC Filing Icon  
7/31/2020Sell3,095$151.90$470,130.504,559View SEC Filing Icon  
3/4/2020Sell4,796$88.82$425,980.721,923View SEC Filing Icon  
11/5/2018Sell1,763$65.75$115,917.253,225View SEC Filing Icon  
8/22/2018Sell2,366$51.44$121,707.044,988View SEC Filing Icon  
6/6/2018Sell1,932$44.31$85,606.927,354View SEC Filing Icon  
3/8/2018Sell4,696$36.16$169,807.369,700View SEC Filing Icon  
3/20/2017Sell4,000$34.83$139,320.0012,594View SEC Filing Icon  
9/14/2016Sell2,700$32.58$87,966.009,394View SEC Filing Icon  
6/30/2016Sell5,000$26.60$133,000.0012,094View SEC Filing Icon  
6/28/2016Sell10,000$24.59$245,900.0027,094View SEC Filing Icon  
5/8/2015Sell20,000$37.19$743,800.00View SEC Filing Icon  
3/19/2015Sell10,000$32.62$326,200.00View SEC Filing Icon  
11/13/2014Sell10,000$23.81$238,100.00View SEC Filing Icon  
6/27/2014Sell10,000$22.41$224,100.00View SEC Filing Icon  
6/24/2014Sell10,000$21.78$217,800.00View SEC Filing Icon  
5/17/2013Sell21,000$8.97$188,370.00View SEC Filing Icon  
5/15/2013Sell86,039$9.01$775,211.39View SEC Filing Icon  
See Full Table

Thomas F. Ryan, Jr. Buying and Selling Activity at Repligen

This chart shows Thomas F Ryan Jr's buying and selling at Repligen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Repligen Company Overview

Repligen logo
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $246.68
Low: $246.68
High: $250.82

50 Day Range

MA: $186.87
Low: $140.68
High: $256.21

2 Week Range

Now: $246.68
Low: $137.21
High: $327.32

Volume

1,266 shs

Average Volume

764,830 shs

Market Capitalization

$13.69 billion

P/E Ratio

89.05

Dividend Yield

N/A

Beta

1.07